Model-Informed Reinforcement Learning for Enabling Precision Dosing Via Adaptive Dosing

被引:3
|
作者
Tosca, Elena Maria [1 ]
De Carlo, Alessandro [1 ]
Ronchi, Davide [1 ]
Magni, Paolo [1 ]
机构
[1] Univ Pavia, Elect Comp & Biomed Engn, Pavia, Italy
关键词
CLOSED-LOOP CONTROL; BISPECTRAL INDEX; TUMOR-GROWTH; PROPOFOL; PHARMACOKINETICS; OPTIMIZATION; CHEMOTHERAPY; PHARMACOLOGY; ANESTHESIA; PACLITAXEL;
D O I
10.1002/cpt.3356
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Precision dosing, the tailoring of drug doses to optimize therapeutic benefits and minimize risks in each patient, is essential for drugs with a narrow therapeutic window and severe adverse effects. Adaptive dosing strategies extend the precision dosing concept to time-varying treatments which require sequential dose adjustments based on evolving patient conditions. Reinforcement learning (RL) naturally fits this paradigm: it perfectly mimics the sequential decision-making process where clinicians adapt dose administration based on patient response and evolution monitoring. This paper aims to investigate the potentiality of coupling RL with population PK/PD models to develop precision dosing algorithms, reviewing the most relevant works in the field. Case studies in which PK/PD models were integrated within RL algorithms as simulation engine to predict consequences of any dosing action have been considered and discussed. They mainly concern propofol-induced anesthesia, anticoagulant therapy with warfarin and a variety of anticancer treatments differing for administered agents and/or monitored biomarkers. The resulted picture highlights a certain heterogeneity in terms of precision dosing approaches, applied methodologies, and degree of adherence to the clinical domain. In addition, a tutorial on how a precision dosing problem should be formulated in terms of the key elements composing the RL framework (i.e., system state, agent actions and reward function), and on how PK/PD models could enhance RL approaches is proposed for readers interested in delving in this field. Overall, the integration of PK/PD models into a RL-framework holds great promise for precision dosing, but further investigations and advancements are still needed to address current limitations and extend the applicability of this methodology to drugs requiring adaptive dosing strategies.
引用
收藏
页码:619 / 636
页数:18
相关论文
共 50 条
  • [21] Model-Informed Precision Dosing of Antibiotics in Pediatric Patients: A Narrative Review
    Abdulla, Alan
    Edwina, Angela E.
    Flint, Robert B.
    Allegaert, Karel
    Wildschut, Enno D.
    Koch, Birgit C. P.
    de Hoog, Matthijs
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [22] Suggestions for Model-Informed Precision Dosing to Optimize Neonatal Drug Therapy
    Euteneuer, Joshua C.
    Kamatkar, Suyog
    Fukuda, Tsuyoshi
    Vinks, Alexander A.
    Akinbi, Henry T.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 59 (02): : 168 - 176
  • [23] Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole
    Anouk M. E. Jansen
    Kim Snijdelaar
    Ron J. Keizer
    Isabel Spriet
    Erwin Dreesen
    Roger J. M. Brüggemann
    Rob ter Heine
    Clinical Pharmacokinetics, 2024, 63 : 645 - 656
  • [24] A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis
    Stijn W. van Beek
    Rob ter Heine
    Jan-Willem C. Alffenaar
    Cecile Magis-Escurra
    Rob E. Aarnoutse
    Elin M. Svensson
    Clinical Pharmacokinetics, 2021, 60 : 943 - 953
  • [25] Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole
    Jansen, Anouk M. E.
    Snijdelaar, Kim
    Keizer, Ron J.
    Spriet, Isabel
    Dreesen, Erwin
    Brueggemann, Roger J. M.
    ter Heine, Rob
    CLINICAL PHARMACOKINETICS, 2024, 63 (05) : 645 - 656
  • [26] Virtual Twins: Understanding the Data Required for Model-Informed Precision Dosing
    Polasek, Thomas M.
    Rostami-Hodjegan, Amin
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 (04) : 742 - 745
  • [27] Model-Informed Precision Dosing for Personalized Ustekinumab Treatment in Plaque Psoriasis
    Rodriguez-Fernandez, Karine
    Zarzoso-Foj, Javier
    Saez-Bello, Marina
    Mateu-Puchades, Almudena
    Martorell-Calatayud, Antonio
    Merino-Sanjuan, Matilde
    Gras-Colomer, Elena
    Climente-Marti, Monica
    Mangas-Sanjuan, Victor
    PHARMACEUTICS, 2024, 16 (10)
  • [28] Model-informed precision dosing to optimise immunosuppressive therapy in renal transplantation
    Zwart, Tom C.
    Guchelaar, Henk-Jan
    van der Boog, Paul J. M.
    Swen, Jesse J.
    van Gelder, Teun
    de Fijter, Johan W.
    Moes, Dirk Jan A. R.
    DRUG DISCOVERY TODAY, 2021, 26 (11) : 2527 - 2546
  • [29] Model-Informed Precision Dosing of Isoniazid: Parametric Population Pharmacokinetics Model Repository
    Ju, Gehang
    Liu, Xin
    Yang, Wenyu
    Xu, Nuo
    Chen, Lulu
    Zhang, Chenchen
    He, Qingfeng
    Zhu, Xiao
    Ouyang, Dongsheng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 801 - 818
  • [30] Model-informed precision dosing of vancomycin in clinical practice: an intervention development study
    Swartling, Maria
    Hamberg, Anna-Karin
    Furebring, Mia
    Tangden, Thomas
    Nielsen, Elisabet I.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2025, 47 (01) : 178 - 186